Results 71 to 80 of about 6,869 (208)

Peer review of the pesticide risk assessment of the active substance Trichoderma atroviride 77B

open access: yesEFSA Journal, Volume 24, Issue 7, July 2026.
Abstract The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, the Netherlands, for the pesticide active substance Trichoderma atroviride 77B and the considerations as regards the inclusion of the substance in Annex IV of Regulation (EC) No 396/2005 ...
European Food Safety Authority (EFSA)   +48 more
wiley   +1 more source

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: A retrospective study [PDF]

open access: yes, 2016
_Background:_ In critically ill patients the incidence of invasive fungal infections caused by Candida spp. has increased remarkably. Echinocandins are recommended as initial treatment for invasive fungal infections. The safety and efficacy of micafungin
Geest, Patrick   +11 more
core   +3 more sources

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

open access: yesBMC Infectious Diseases, 2011
Background Candida albicans is the most common cause of candidemia and other forms of invasive candidiasis. Systemic infections due to C. albicans exhibit good susceptibility to fluconazole and echinocandins.
Reisman Arlene L   +8 more
doaj   +1 more source

Peer review of the pesticide risk assessment of the active substance Trichoderma harzianum T78

open access: yesEFSA Journal, Volume 24, Issue 7, July 2026.
Abstract The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, The Netherlands, for the pesticide active substance Trichoderma harzianum T78 and the considerations as regards the inclusion of the substance in Annex IV ...
European Food Safety Authority (EFSA)   +48 more
wiley   +1 more source

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration

open access: yes, 2011
Background: Clinical studies support a role for anidulafungin as first-line treatment of invasive candidiasis in critically ill patients and postulate no need for dose adjustments in mild to severe renal failure.
Meyer, Brigitte (Medizinische Universität Wien)   +7 more
core   +1 more source

An Update on the Current Practice on the Management of Fungal Necrotizing Otitis Externa: A Systematic Analysis of the Literature

open access: yesEye &ENT Research, Volume 3, Issue 2, Page 59-68, June 2026.
ABSTRACT Malignant otitis externa (MOE), necrotizing otitis externa (NOE), or skull base osteomyelitis (SBO) is a severe ear infection, primarily caused by Pseudomonas aeruginosa with 5%–20% of cases due to fungal species. Fungal NOE affects immunocompromised patients.
Mohammed A. Elkrim Saad Mohammed   +8 more
wiley   +1 more source

Low but Sufficient Anidulafungin Exposure in Critically Ill Patients

open access: yes, 2014
The efficacy of anidulafungin is driven by the area under the concentration-time curve (AUC)/MIC ratio. Patients in intensive care may be at risk for underexposure. In critically ill patients with an invasive Candida infection, the anidulafungin exposure
Alffenaar, Jan-Willem C.   +9 more
core   +1 more source

Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis

open access: yesFrontiers in Pharmacology
BackgroundThis meta-analysis aims to evaluate the effectiveness and safety of combining echinocandins with standard of care (SOC) antifungal drugs for treating invasive aspergillosis infection (IAI).MethodWe searched PubMed, Embase, and Cochrane Library ...
Yazed Saleh Alsowaida   +6 more
doaj   +1 more source

Oral Cryptococcosis due to Naganishia diffluens in a Patient With Thalassemia: A Case Report and a Literature Review

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 11, June 2026.
Naganishia diffluens, a rare non‐neoformans cryptococcal species, was identified by PCR sequencing as the causative agent of oral cryptococcosis in a 31‐year‐old Iranian man with β‐thalassemia. This case represents the first documented instance of oral infection by N.
Zahra Yahyazadeh   +13 more
wiley   +1 more source

In vitro effectiveness of Anidulafungin against Candida sp. biofilms

open access: yes, 2013
This study furnishes deeper insights to previous works on anidulafungin, demonstrating the potent activity against Candida strains planktonic cells and biofilms.
Carone A   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy